Suspected clozapine poisoning in the UK/Eire, 1992–2003

Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and N-desmethylclozapine (norclozapine) were measured in order to assess the relationship...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Forensic science international 2005-12, Vol.155 (2), p.91-99
Hauptverfasser: Flanagan, R.J., Spencer, E.P., Morgan, P.E., Barnes, T.R.E., Dunk, L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 99
container_issue 2
container_start_page 91
container_title Forensic science international
container_volume 155
creator Flanagan, R.J.
Spencer, E.P.
Morgan, P.E.
Barnes, T.R.E.
Dunk, L.
description Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and N-desmethylclozapine (norclozapine) were measured in order to assess the relationship of these parameters to outcome. Samples were referred from clinicians, pathologists/coroners, or via the Clozaril Patient Monitoring Service (CPMS, Novartis). Information was gathered from clinical, post-mortem, or coroners’ reports. There were seven fatal [five male, two female; median (range) age 28 (24–41) year] and five non-fatal [four male, one female; median age 35 (26–41) year] clozapine overdoses. The median post-mortem blood clozapine and norclozapine concentrations were 8.2 (3.7–12) and 1.9 (1.4–2.4) mg/L, respectively [median clozapine:norclozapine ratio 4.4 (2.9–5.1)]. The median plasma clozapine and norclozapine concentrations (first or only sample) were 3.9 (1.7–7.0) and 0.40 (0.30–0.70) mg/L, respectively [median clozapine:norclozapine ratio 7.6 (5.3–18)] in the remainder. These overdoses were in patients who were poorly or non-adherent to clozapine, or who had taken tablets prescribed for someone else. In 54 further people who died whilst receiving clozapine [38 male, 16 female; median age 41 (22–70) year], the median post-mortem blood clozapine and norclozapine concentrations were 1.9 (0–7.7, n = 43) and 1.4 (0–6.0, n = 39) mg/L, respectively [median clozapine:norclozapine ratio 1.5 (0.4–7.6, n = 38)]. The median post-mortem increase in blood clozapine and norclozapine as compared to the most recent ante-mortem measurement was 489 (98–5350)% and 371 (139–831)%, respectively [median sample time before death 14 (0–30, n = 21) days]. Clozapine poisoning cannot be diagnosed on the basis of blood clozapine and norclozapine concentrations alone. The analysis of ante-mortem blood specimens collected originally for white cell count monitoring and the blood clozapine:norclozapine ratio may provide additional interpretative information.
doi_str_mv 10.1016/j.forsciint.2004.10.024
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_17190859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A138862010</galeid><els_id>S0379073804007455</els_id><sourcerecordid>A138862010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-3fb12705ba1af7a6a9585492a95c0ffc5c43289731dc9151c8a1b0730d91059d3</originalsourceid><addsrcrecordid>eNqFkc2KFDEUhYMoTtv6ClogurJ68lNJJctmGH9wwIXOOqRTN22a6qRMqgRdzTvMG_okpujGRmmQLC7cfOfekxyEXhC8IpiIy93KxZSt92FcUYyb0l1h2jxACyJbWgsq2UO0wKxVNW6ZvEBPct5hjDmn4jG6IIJSQRqxQOrzlAewI3SV7eNPM_gA1RB9jsGHbeVDNX6F6vbj5bVP8KYiStFfd_dlJXuKHjnTZ3h2rEt0-_b6y9X7-ubTuw9X65vacsHGmrkNoS3mG0OMa40wikveKFqqxc5ZbhtGpWoZ6awinFhpyKZ4xp0imKuOLdHrw9whxW8T5FHvfbbQ9yZAnLImLVFYclXAl_-AuzilULxpghmTjGFBT9TW9KB9cHFMxs4j9ZowKQXFhV6i-gy1hQDJ9DGA86X9F786w5fTwd7bs4L2ILAp5pzA6SH5vUk_ilc9R6x3-k_Eeo54vigRF-Xz4zOnzR66k-6YaQFeHQGTreldMsH6fOJaSlpO559YHzgo6X33kHTZBsFCV6K2o-6i_6-Z363gwzo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1033833062</pqid></control><display><type>article</type><title>Suspected clozapine poisoning in the UK/Eire, 1992–2003</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Flanagan, R.J. ; Spencer, E.P. ; Morgan, P.E. ; Barnes, T.R.E. ; Dunk, L.</creator><creatorcontrib>Flanagan, R.J. ; Spencer, E.P. ; Morgan, P.E. ; Barnes, T.R.E. ; Dunk, L.</creatorcontrib><description>Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and N-desmethylclozapine (norclozapine) were measured in order to assess the relationship of these parameters to outcome. Samples were referred from clinicians, pathologists/coroners, or via the Clozaril Patient Monitoring Service (CPMS, Novartis). Information was gathered from clinical, post-mortem, or coroners’ reports. There were seven fatal [five male, two female; median (range) age 28 (24–41) year] and five non-fatal [four male, one female; median age 35 (26–41) year] clozapine overdoses. The median post-mortem blood clozapine and norclozapine concentrations were 8.2 (3.7–12) and 1.9 (1.4–2.4) mg/L, respectively [median clozapine:norclozapine ratio 4.4 (2.9–5.1)]. The median plasma clozapine and norclozapine concentrations (first or only sample) were 3.9 (1.7–7.0) and 0.40 (0.30–0.70) mg/L, respectively [median clozapine:norclozapine ratio 7.6 (5.3–18)] in the remainder. These overdoses were in patients who were poorly or non-adherent to clozapine, or who had taken tablets prescribed for someone else. In 54 further people who died whilst receiving clozapine [38 male, 16 female; median age 41 (22–70) year], the median post-mortem blood clozapine and norclozapine concentrations were 1.9 (0–7.7, n = 43) and 1.4 (0–6.0, n = 39) mg/L, respectively [median clozapine:norclozapine ratio 1.5 (0.4–7.6, n = 38)]. The median post-mortem increase in blood clozapine and norclozapine as compared to the most recent ante-mortem measurement was 489 (98–5350)% and 371 (139–831)%, respectively [median sample time before death 14 (0–30, n = 21) days]. Clozapine poisoning cannot be diagnosed on the basis of blood clozapine and norclozapine concentrations alone. The analysis of ante-mortem blood specimens collected originally for white cell count monitoring and the blood clozapine:norclozapine ratio may provide additional interpretative information.</description><identifier>ISSN: 0379-0738</identifier><identifier>EISSN: 1872-6283</identifier><identifier>DOI: 10.1016/j.forsciint.2004.10.024</identifier><identifier>PMID: 16226146</identifier><identifier>CODEN: FSINDR</identifier><language>eng</language><publisher>Kidlington: Elsevier Ireland Ltd</publisher><subject>Adult ; Aged ; Analysis ; Antipsychotic Agents - blood ; Antipsychotic Agents - poisoning ; Biological and medical sciences ; Clozapine ; Clozapine - analogs &amp; derivatives ; Clozapine - blood ; Clozapine - poisoning ; Drug dosages ; Drug Overdose ; Drug therapy ; Fatal poisoning: clozapine ; Fatal poisoning: interpretation of results ; Female ; Forensic Medicine ; Forensic sciences ; Forensic toxicology ; General aspects ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Leukocyte Count ; Male ; Medical sciences ; Middle Aged ; Plasma ; Plasma:whole blood distribution: clozapine ; Poisoning ; Poisoning - diagnosis ; Post-mortem redistribution: clozapine ; Postmortem Changes ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Substance abuse treatment ; Suicide ; Toxicity ; Treatment Refusal ; United Kingdom</subject><ispartof>Forensic science international, 2005-12, Vol.155 (2), p.91-99</ispartof><rights>2004 Elsevier Ireland Ltd</rights><rights>2005 INIST-CNRS</rights><rights>COPYRIGHT 2005 The Lancet Publishing Group, a division of Elsevier Science Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-3fb12705ba1af7a6a9585492a95c0ffc5c43289731dc9151c8a1b0730d91059d3</citedby><cites>FETCH-LOGICAL-c563t-3fb12705ba1af7a6a9585492a95c0ffc5c43289731dc9151c8a1b0730d91059d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0379073804007455$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17217522$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16226146$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Flanagan, R.J.</creatorcontrib><creatorcontrib>Spencer, E.P.</creatorcontrib><creatorcontrib>Morgan, P.E.</creatorcontrib><creatorcontrib>Barnes, T.R.E.</creatorcontrib><creatorcontrib>Dunk, L.</creatorcontrib><title>Suspected clozapine poisoning in the UK/Eire, 1992–2003</title><title>Forensic science international</title><addtitle>Forensic Sci Int</addtitle><description>Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and N-desmethylclozapine (norclozapine) were measured in order to assess the relationship of these parameters to outcome. Samples were referred from clinicians, pathologists/coroners, or via the Clozaril Patient Monitoring Service (CPMS, Novartis). Information was gathered from clinical, post-mortem, or coroners’ reports. There were seven fatal [five male, two female; median (range) age 28 (24–41) year] and five non-fatal [four male, one female; median age 35 (26–41) year] clozapine overdoses. The median post-mortem blood clozapine and norclozapine concentrations were 8.2 (3.7–12) and 1.9 (1.4–2.4) mg/L, respectively [median clozapine:norclozapine ratio 4.4 (2.9–5.1)]. The median plasma clozapine and norclozapine concentrations (first or only sample) were 3.9 (1.7–7.0) and 0.40 (0.30–0.70) mg/L, respectively [median clozapine:norclozapine ratio 7.6 (5.3–18)] in the remainder. These overdoses were in patients who were poorly or non-adherent to clozapine, or who had taken tablets prescribed for someone else. In 54 further people who died whilst receiving clozapine [38 male, 16 female; median age 41 (22–70) year], the median post-mortem blood clozapine and norclozapine concentrations were 1.9 (0–7.7, n = 43) and 1.4 (0–6.0, n = 39) mg/L, respectively [median clozapine:norclozapine ratio 1.5 (0.4–7.6, n = 38)]. The median post-mortem increase in blood clozapine and norclozapine as compared to the most recent ante-mortem measurement was 489 (98–5350)% and 371 (139–831)%, respectively [median sample time before death 14 (0–30, n = 21) days]. Clozapine poisoning cannot be diagnosed on the basis of blood clozapine and norclozapine concentrations alone. The analysis of ante-mortem blood specimens collected originally for white cell count monitoring and the blood clozapine:norclozapine ratio may provide additional interpretative information.</description><subject>Adult</subject><subject>Aged</subject><subject>Analysis</subject><subject>Antipsychotic Agents - blood</subject><subject>Antipsychotic Agents - poisoning</subject><subject>Biological and medical sciences</subject><subject>Clozapine</subject><subject>Clozapine - analogs &amp; derivatives</subject><subject>Clozapine - blood</subject><subject>Clozapine - poisoning</subject><subject>Drug dosages</subject><subject>Drug Overdose</subject><subject>Drug therapy</subject><subject>Fatal poisoning: clozapine</subject><subject>Fatal poisoning: interpretation of results</subject><subject>Female</subject><subject>Forensic Medicine</subject><subject>Forensic sciences</subject><subject>Forensic toxicology</subject><subject>General aspects</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Leukocyte Count</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Plasma</subject><subject>Plasma:whole blood distribution: clozapine</subject><subject>Poisoning</subject><subject>Poisoning - diagnosis</subject><subject>Post-mortem redistribution: clozapine</subject><subject>Postmortem Changes</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Substance abuse treatment</subject><subject>Suicide</subject><subject>Toxicity</subject><subject>Treatment Refusal</subject><subject>United Kingdom</subject><issn>0379-0738</issn><issn>1872-6283</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkc2KFDEUhYMoTtv6ClogurJ68lNJJctmGH9wwIXOOqRTN22a6qRMqgRdzTvMG_okpujGRmmQLC7cfOfekxyEXhC8IpiIy93KxZSt92FcUYyb0l1h2jxACyJbWgsq2UO0wKxVNW6ZvEBPct5hjDmn4jG6IIJSQRqxQOrzlAewI3SV7eNPM_gA1RB9jsGHbeVDNX6F6vbj5bVP8KYiStFfd_dlJXuKHjnTZ3h2rEt0-_b6y9X7-ubTuw9X65vacsHGmrkNoS3mG0OMa40wikveKFqqxc5ZbhtGpWoZ6awinFhpyKZ4xp0imKuOLdHrw9whxW8T5FHvfbbQ9yZAnLImLVFYclXAl_-AuzilULxpghmTjGFBT9TW9KB9cHFMxs4j9ZowKQXFhV6i-gy1hQDJ9DGA86X9F786w5fTwd7bs4L2ILAp5pzA6SH5vUk_ilc9R6x3-k_Eeo54vigRF-Xz4zOnzR66k-6YaQFeHQGTreldMsH6fOJaSlpO559YHzgo6X33kHTZBsFCV6K2o-6i_6-Z363gwzo</recordid><startdate>20051220</startdate><enddate>20051220</enddate><creator>Flanagan, R.J.</creator><creator>Spencer, E.P.</creator><creator>Morgan, P.E.</creator><creator>Barnes, T.R.E.</creator><creator>Dunk, L.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><general>The Lancet Publishing Group, a division of Elsevier Science Ltd</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ILT</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20051220</creationdate><title>Suspected clozapine poisoning in the UK/Eire, 1992–2003</title><author>Flanagan, R.J. ; Spencer, E.P. ; Morgan, P.E. ; Barnes, T.R.E. ; Dunk, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-3fb12705ba1af7a6a9585492a95c0ffc5c43289731dc9151c8a1b0730d91059d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Analysis</topic><topic>Antipsychotic Agents - blood</topic><topic>Antipsychotic Agents - poisoning</topic><topic>Biological and medical sciences</topic><topic>Clozapine</topic><topic>Clozapine - analogs &amp; derivatives</topic><topic>Clozapine - blood</topic><topic>Clozapine - poisoning</topic><topic>Drug dosages</topic><topic>Drug Overdose</topic><topic>Drug therapy</topic><topic>Fatal poisoning: clozapine</topic><topic>Fatal poisoning: interpretation of results</topic><topic>Female</topic><topic>Forensic Medicine</topic><topic>Forensic sciences</topic><topic>Forensic toxicology</topic><topic>General aspects</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Leukocyte Count</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Plasma</topic><topic>Plasma:whole blood distribution: clozapine</topic><topic>Poisoning</topic><topic>Poisoning - diagnosis</topic><topic>Post-mortem redistribution: clozapine</topic><topic>Postmortem Changes</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Substance abuse treatment</topic><topic>Suicide</topic><topic>Toxicity</topic><topic>Treatment Refusal</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flanagan, R.J.</creatorcontrib><creatorcontrib>Spencer, E.P.</creatorcontrib><creatorcontrib>Morgan, P.E.</creatorcontrib><creatorcontrib>Barnes, T.R.E.</creatorcontrib><creatorcontrib>Dunk, L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale OneFile: LegalTrac</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Forensic science international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flanagan, R.J.</au><au>Spencer, E.P.</au><au>Morgan, P.E.</au><au>Barnes, T.R.E.</au><au>Dunk, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suspected clozapine poisoning in the UK/Eire, 1992–2003</atitle><jtitle>Forensic science international</jtitle><addtitle>Forensic Sci Int</addtitle><date>2005-12-20</date><risdate>2005</risdate><volume>155</volume><issue>2</issue><spage>91</spage><epage>99</epage><pages>91-99</pages><issn>0379-0738</issn><eissn>1872-6283</eissn><coden>FSINDR</coden><abstract>Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and N-desmethylclozapine (norclozapine) were measured in order to assess the relationship of these parameters to outcome. Samples were referred from clinicians, pathologists/coroners, or via the Clozaril Patient Monitoring Service (CPMS, Novartis). Information was gathered from clinical, post-mortem, or coroners’ reports. There were seven fatal [five male, two female; median (range) age 28 (24–41) year] and five non-fatal [four male, one female; median age 35 (26–41) year] clozapine overdoses. The median post-mortem blood clozapine and norclozapine concentrations were 8.2 (3.7–12) and 1.9 (1.4–2.4) mg/L, respectively [median clozapine:norclozapine ratio 4.4 (2.9–5.1)]. The median plasma clozapine and norclozapine concentrations (first or only sample) were 3.9 (1.7–7.0) and 0.40 (0.30–0.70) mg/L, respectively [median clozapine:norclozapine ratio 7.6 (5.3–18)] in the remainder. These overdoses were in patients who were poorly or non-adherent to clozapine, or who had taken tablets prescribed for someone else. In 54 further people who died whilst receiving clozapine [38 male, 16 female; median age 41 (22–70) year], the median post-mortem blood clozapine and norclozapine concentrations were 1.9 (0–7.7, n = 43) and 1.4 (0–6.0, n = 39) mg/L, respectively [median clozapine:norclozapine ratio 1.5 (0.4–7.6, n = 38)]. The median post-mortem increase in blood clozapine and norclozapine as compared to the most recent ante-mortem measurement was 489 (98–5350)% and 371 (139–831)%, respectively [median sample time before death 14 (0–30, n = 21) days]. Clozapine poisoning cannot be diagnosed on the basis of blood clozapine and norclozapine concentrations alone. The analysis of ante-mortem blood specimens collected originally for white cell count monitoring and the blood clozapine:norclozapine ratio may provide additional interpretative information.</abstract><cop>Kidlington</cop><pub>Elsevier Ireland Ltd</pub><pmid>16226146</pmid><doi>10.1016/j.forsciint.2004.10.024</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0379-0738
ispartof Forensic science international, 2005-12, Vol.155 (2), p.91-99
issn 0379-0738
1872-6283
language eng
recordid cdi_proquest_miscellaneous_17190859
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Aged
Analysis
Antipsychotic Agents - blood
Antipsychotic Agents - poisoning
Biological and medical sciences
Clozapine
Clozapine - analogs & derivatives
Clozapine - blood
Clozapine - poisoning
Drug dosages
Drug Overdose
Drug therapy
Fatal poisoning: clozapine
Fatal poisoning: interpretation of results
Female
Forensic Medicine
Forensic sciences
Forensic toxicology
General aspects
Humans
Investigative techniques, diagnostic techniques (general aspects)
Leukocyte Count
Male
Medical sciences
Middle Aged
Plasma
Plasma:whole blood distribution: clozapine
Poisoning
Poisoning - diagnosis
Post-mortem redistribution: clozapine
Postmortem Changes
Public health. Hygiene
Public health. Hygiene-occupational medicine
Substance abuse treatment
Suicide
Toxicity
Treatment Refusal
United Kingdom
title Suspected clozapine poisoning in the UK/Eire, 1992–2003
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A48%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suspected%20clozapine%20poisoning%20in%20the%20UK/Eire,%201992%E2%80%932003&rft.jtitle=Forensic%20science%20international&rft.au=Flanagan,%20R.J.&rft.date=2005-12-20&rft.volume=155&rft.issue=2&rft.spage=91&rft.epage=99&rft.pages=91-99&rft.issn=0379-0738&rft.eissn=1872-6283&rft.coden=FSINDR&rft_id=info:doi/10.1016/j.forsciint.2004.10.024&rft_dat=%3Cgale_proqu%3EA138862010%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1033833062&rft_id=info:pmid/16226146&rft_galeid=A138862010&rft_els_id=S0379073804007455&rfr_iscdi=true